AMOEBA (EPA:ALMIB) | Finanzwire

BRIEF

published on 11/21/2024 at 17:50, 1 day 15 hours ago

Amoéba publishes an article on its cosmetic innovation

AMOEBA Innovation Cosmetic Willaertia Lysate Skin Aging
PRESS RELEASE

published on 11/21/2024 at 17:45, 1 day 15 hours ago

Amoéba announces the publication of a first scientific article on the efficacy of its innovation in cosmetics
Amoéba announces publication of a scientific article on the efficacy of Willaertia lysate in Cosmetics journal. Discover the natural microbiological solution's benefits for skin anti-aging

AMOEBA Willaertia Lysate Cosmetics Journal Skin Anti-aging Microbiological Solution
BRIEF

published on 10/07/2024 at 17:50, 1 month 15 days ago

Amoéba Publishes its Half-Yearly Financial Report as of June 30, 2024

AMOEBA Investors Financial Report Biocontrol Cosmetic
PRESS RELEASE

published on 10/07/2024 at 17:45, 1 month 15 days ago

Amoéba: Publication of the half-year financial report at 30 June 2024
Amoéba announces the publication of its half-year financial report for 2024 and upcoming institutional investor event. Amoéba, a greentech company, provides natural microbiological solutions

AMOEBA Investor Event Half-year Financial Report GreenTech Microbiological Solutions
BRIEF

published on 10/03/2024 at 17:50, 1 month 19 days ago

Amoéba confirms its strategic pivot in the first half of 2024

AMOEBA Strategy Biocontrol GreenTech Cosmetic
PRESS RELEASE

published on 10/03/2024 at 17:45, 1 month 19 days ago

Amoéba: the first half of 2024 confirms the strategic pivot towards an industrial and commercial company from 2025 onwards
Amoéba reports strategic shift to commercial focus & positive operating income growth in H1 2024. Financial outlook secured until mid-2025. Development plans for biocontrol & cosmetics segments

AMOEBA Financial Results Biocontrol Cosmetics Strategic Shift
BRIEF

published on 10/02/2024 at 17:50, 1 month 20 days ago

AMOEBA: Total number of voting rights and shares as of September 30, 2024

AMOEBA Voting Rights Capital Actions Financial Markets
BRIEF

published on 08/28/2024 at 17:50, 2 months 25 days ago

Amoéba Prepares for US Launch of AXPERA Product Line by 2025

Market Authorization 2025 Targets AXPERA Launch EPA Approval Biocontrol Products
PRESS RELEASE

published on 08/28/2024 at 17:45, 2 months 25 days ago

AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025
Amoéba's biofungicide products receive US EPA's admissibility confirmation for registration dossier, accelerating industrial and commercial development. Application for market authorization has been submitted. Collaboration with Dunham Trimmer in progress

AMOEBA Collaboration Market Authorization Biofungicide US EPA
BRIEF

published on 07/02/2024 at 08:35, 4 months 21 days ago

AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES

AMOEBA Biocontrol Cosmetics Legal Reorganisation Subsidiary

1 2 ... 4

Published on 11/22/2024 at 23:55, 9 hours 31 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 56 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 21 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 10 hours 21 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 56 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 15 hours 11 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 15 hours 26 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 15 hours 32 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 30 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 26 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 18 hours 51 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 2 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News